Sep 3, 2021
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025
COMBINED sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol and Sativex – are set to reach €1.8 billion by 2025, according to a new report. The Pharmaceutical Cannabis Report: 2nd Edition, from global cannabis industry consultants Prohibition Partners, finds that research on the endocannabinoid system is one of the most promising – and potentially…
View On WordPress